What Genospace does

Genospace is a precision medicine software platform that enables community oncology practices and research sites to participate in clinical research by integrating clinical, genomic, and real-world patient data. The company serves more than 500 community oncology clinics and research sites in the United States, a footprint it states reaches approximately 1 in 5 cancer patients through its affiliated network. Its core mission is bridging the gap between clinical research and clinical care for community-based practices that lack the infrastructure to operationalize precision medicine independently.

The platform is composed of three integrated modules: Genospace Trial Match, which performs clinical-genomic patient matching against open trials to alert providers of eligible patients; Genospace E2E, which automates transfer of data from a site's source EMR system into clinical trial databases without manual coordinator intervention; and Genospace Feasibility, which evaluates site enrollment potential based on historical accrual, competing trials, and population measures. Underlying technology integrates clinical-genomic and biomarker data into day-to-day oncology workflows, and the company claims sites on the platform experience a 50%+ increase in interventional trial enrollments.

Genospace operates a B2B enterprise sales motion, selling platform subscriptions or service agreements directly to healthcare organizations; pricing is not publicly disclosed. The firm was founded in 2012 (per company history and copyright notice), is headquartered in Boston, Massachusetts, operates as Genospace, LLC, and was previously known as Ontada Health. Strategic partners include Sarah Cannon Research Institute (SCRI) and Precision Care Companion (PCC), and the company's privacy notice references McKesson, suggesting a corporate affiliation with McKesson's US Oncology Network ecosystem. The only disclosed funding event was a $5M round from Thomson Reuters in 2014, and the company remains private with 11–50 employees.

Name

Genospace

Legal name

Genospace, LLC

Website

https://genospace.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Genospace is a precision medicine software platform serving 500+ US community oncology clinics and research sites with clinical-genomic trial matching, EMR-to-EDC integration, and study feasibility tools, reaching roughly 1 in 5 US cancer patients.

Ownership category

akta.pro rank

Product category

Precision Medicine Software for Oncology Clinical Research

NAICS

Software Publishers (51321)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Electronic Data Capture (EDC) Platforms (HLACAOAA), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Precision medicine software
• Clinical trial matching
• EMR-to-EDC integration
• Oncology research platform
• Clinical-genomic data

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Platform/SaaS Subscription: Genospace operates as a software/platform company providing technology services to community oncology practices and research sites. The platform appears to be sold as a subscription or service agreement to healthcare organizations seeking to participate in clinical research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Genospace sells a precision medicine software platform that integrates clinical, genomic, and real-world data to help community oncology practices participate in clinical research. Its three core modules are Genospace Trial Match (clinical-genomic trial matching and menu management), Genospace E2E (automated EMR-to-EDC data integration), and Genospace Feasibility (study feasibility and site selection assessment), all delivered as an integrated platform for healthcare providers and research sites.

Product overview

Genospace offers a unified platform of three integrated modules designed to bridge clinical research and clinical care for community oncology practices. The core offering includes Genospace Trial Match (clinical-genomic trial matching), Genospace E2E (EMR-to-EDC data integration), and Genospace Feasibility (site enrollment assessment). The platform enables practices to deliver precision medicine at scale by integrating biomarker data and clinical trial matching into everyday workflows, with collaboration through Precision Care Companion (PCC) and the Sarah Cannon Research Institute.

Differentiator

Problem solved

Functional benefit

Brands

• Genospace Trial Match: Clinical trial matching platform incorporating clinical-genomic patient data to identify patients eligible for studies at their office.
• Genospace E2E
• Genospace Feasibility

Products and services

• Genospace Trial Match Clinical trial matching platform incorporating clinical-genomic patient data that alerts providers when patients at their office are eligible for studies currently open to enrollment, designed to increase trial accruals for community oncology sites.
• Genospace E2E (EMR-to-EDC Integration) Integration solution that automatically transfers data captured in a site's source EMR system to a clinical trial database without requiring a data coordinator to trigger the transfer, saving research-site time.
• Genospace Feasibility Study feasibility and site selection tool that evaluates a site's enrollment potential for new study opportunities by assessing past enrollment rates, competing trials, and population measures, enabling data-driven assessments.

Quantifiable outcome

• 50%+ increase in interventional trial enrollments among sites using the platform
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Precision Care Companion (PCC)coreStrategic or Co-development PartnerGenospace has collaborated with Precision Care Companion (PCC) to empower community oncology practices to deliver precision medicine at scale. Through this collaboration, biomarker data and clinical trial matching are integrated into everyday clinical workflows.
• Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerThrough collaboration with SCRI, Genospace enables data-driven decisions that connect patients to targeted therapies and research opportunities. SCRI's Chief Scientific Officer Dr. David Spigel has provided a testimonial endorsement of the platform.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Flatiron Health: Oncology-focused clinical and real-world data platform that aggregates EMR data and supports clinical research and trial matching in community oncology. Highly comparable on customer base (community oncology practices, academic sites) and product category (clinical-genomic data for research).
• Medidata (Dassault Systèmes): Industry-leading clinical trial technology platform offering EDC, CTMS, eCOA, and trial design/randomization software. Competes directly with Genospace's E2E (EMR-to-EDC) integration and trial matching capabilities for sites and sponsors.
• Veeva Systems: Cloud software provider for life sciences with a clinical trial suite (Veeva Vault CTMS, eTMF, EDC). Comparable SaaS delivery model, life-sciences customer base, and overlap in EDC and trial operations tools.
• Tempus Labs: Precision medicine data and AI platform combining genomic sequencing, clinical data, and trial matching to support oncology care and research. Directly comparable on clinical-genomic data integration and precision oncology workflow positioning.
• ConcertAI: Oncology-focused real-world evidence and AI company serving pharma sponsors, providers, and research sites with clinical-genomic data products. Comparable customer segments and precision oncology research use cases.
• Syapse: Precision oncology platform that integrates clinical, molecular, and outcomes data for community health systems and life sciences partners. Comparable precision-oncology positioning and community-site customer base.

Broad incumbents

• IQVIA: Global clinical research services and technology provider with a broad portfolio spanning EDC, CTMS, real-world data, and CRO services. Overlaps with Genospace across clinical trial technology but operates at far greater scale and breadth.

Emerging players

• Deep 6 AI: AI-driven clinical trial matching platform that mines EHR data to identify eligible patients for studies. Competes with Genospace Trial Match, with broader therapeutic focus but smaller oncology footprint.
• Mendel (Mendel Health): AI platform for clinical trial feasibility and patient matching, with significant oncology exposure. Comparable on trial matching and feasibility use cases for pharma and research sites.

Others

• Foundation Medicine: Molecular diagnostics and genomic profiling company that generates biomarker data frequently consumed by precision oncology workflows like Genospace. Adjacent rather than directly competitive, but ecosystem-relevant for genomic data inputs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/GENOSPACE
• Facebookfacebook.com/GenoSpaceLLC
• LinkedInlinkedin.com/company/genospace

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genospace